Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Clinical Orthopaedics and Related Research®
Published in: Clinical Orthopaedics and Related Research® 2/2013

01-02-2013 | Clinical Research

Estimating Risk in Medicare Patients With THA: An Electronic Risk Calculator for Periprosthetic Joint Infection and Mortality

Authors: Kevin J. Bozic, MD, MBA, Kevin Ong, PhD, Edmund Lau, MS, Daniel J. Berry, MD, Thomas P. Vail, MD, Steven M. Kurtz, PhD, Harry E. Rubash, MD

Published in: Clinical Orthopaedics and Related Research® | Issue 2/2013

Login to get access

Abstract

Background

Although risk factors for periprosthetic joint infection (PJI) and mortality after total hip arthroplasty (THA) have been identified, interactions between specific patient risk factors are poorly understood. Therefore, it is difficult for surgeons to counsel patients on their individual risk of PJI or mortality after THA.

Questions/purposes

We evaluated the interaction between patient clinical and demographic factors on the risk of PJI and mortality after THA and developed an electronic risk calculator for estimating the patient-specific risk of PJI and mortality in Medicare patients with THA.

Methods

We used the Medicare 5% sample claims database to calculate the risk of PJI within 2 years and mortality within 90 days after THA in 53,252 Medicare patients with primary THAs between 1998 and 2009. Logistic regression using 29 comorbid conditions, age, sex, race, and socioeconomic status were used as inputs to develop an electronic risk calculator to estimate patient-specific risk of PJI and mortality after THA.

Results

The overall 2-year risk of PJI and 90-day risk of mortality after primary THA were 2.07% and 1.30%, respectively. White women aged 70 to 74 years with alcohol abuse, depression, electrolyte disorder, peptic ulcer disease, urinary tract infection, rheumatologic disease, preoperative anemia, cardiopulmonary (cardiac arrhythmia, congestive heart failure, ischemic heart disease, chronic pulmonary disease) comorbidities, and peripheral vascular disease were at highest risk for PJI. White women aged 65 to 69 years with electrolyte disorder, hemiplegia/paraplegia, hypertension, hypothyroidism, metastatic tumor, preoperative anemia, coagulopathy, cardiopulmonary (congestive heart failure, chronic pulmonary disease) and psychiatric (psychoses, depression) comorbidities, malignancies, and peripheral vascular disease were at highest risk for mortality. An electronic risk calculator was developed to estimate the risk of PJI and mortality in Medicare patients with THA.

Conclusions

This electronic risk calculator can be used to counsel Medicare patients regarding their patient-specific risks of PJI and mortality after THA.

Level of Evidence

Level II, prognostic study. See the Instructions for Authors for a complete description of levels of evidence.
Literature
1.
2.
Bozic KJ, Lau E, Kurtz S, Ong K, Berry DJ. Patient-related risk factors for postoperative mortality and periprosthetic joint infection in Medicare patients undergoing TKA. Clin Orthop Relat Res. 2012;470:130–137.PubMedCrossRef
3.
Dearborn JT, Harris WH. Postoperative mortality after total hip arthroplasty: an analysis of deaths after two thousand seven hundred and thirty-six procedures. J Bone Joint Surg Am. 1998;80:1291–1294.PubMed
4.
5.
Franko OI, Tirrell TF. Smartphone app use among medical providers in ACGME training programs. J Med Syst. 2012;36:3135–3139.PubMedCrossRef
6.
Gaston MS, Amin AK, Clayton RA, Brenkel IJ. Does a history of cardiac disease or hypertension increase mortality following primary elective total hip arthroplasty? Surgeon. 2007;5:260–265.PubMedCrossRef
7.
Hamel MB, Toth M, Legedza A, Rosen MP. Joint replacement surgery in elderly patients with severe osteoarthritis of the hip or knee: decision making, postoperative recovery, and clinical outcomes. Arch Intern Med. 2008;168:1430–1440.PubMedCrossRef
8.
Lai K, Bohm ER, Burnell C, Hedden DR. Presence of medical comorbidities in patients with infected primary hip or knee arthroplasties. J Arthroplasty. 2007;22:651–656.PubMedCrossRef
9.
Mantilla CB, Horlocker TT, Schroeder DR, Berry DJ, Brown DL. Frequency of myocardial infarction, pulmonary embolism, deep venous thrombosis, and death following primary hip or knee arthroplasty. Anesthesiology. 2002;96:1140–1146.PubMedCrossRef
10.
Mariconda M, Galasso O, Costa GG, Recano P, Cerbasi S. Quality of life and functionality after total hip arthroplasty: a long-term follow-up study. BMC Musculoskelet Disord. 2011;12:222.PubMedCrossRef
11.
Miller KA, Callaghan JJ, Goetz DD, Johnston RC. Early postoperative mortality following total hip arthroplasty in a community setting: a single surgeon experience. Iowa Orthop J. 2003;23:36–42.PubMed
12.
Ong KL, Kurtz SM, Lau E, Bozic KJ, Berry DJ, Parvizi J. Prosthetic joint infection risk after total hip arthroplasty in the Medicare population. J Arthroplasty. 2009;24(6 suppl):105–109.PubMedCrossRef
13.
Parvizi J, Johnson BG, Rowland C, Ereth MH, Lewallen DG. Thirty-day mortality after elective total hip arthroplasty. J Bone Joint Surg Am. 2001;83:1524–1528.PubMed
14.
Rat AC, Guillemin F, Osnowycz G, Delagoutte JP, Cuny C, Mainard D, Baumann C. Total hip or knee replacement for osteoarthritis: mid- and long-term quality of life. Arthritis Care Res (Hoboken). 2010;62:54–62.CrossRef
15.
Rosser BA, Eccleston C. Smartphone applications for pain management. J Telemed Telecare. 2011;17:308–312.PubMedCrossRef
16.
Surin VV, Sundholm K, Backman L. Infection after total hip replacement: with special reference to a discharge from the wound. J Bone Joint Surg Br. 1983;65:412–418.PubMed
Metadata
Title
Estimating Risk in Medicare Patients With THA: An Electronic Risk Calculator for Periprosthetic Joint Infection and Mortality
Authors
Kevin J. Bozic, MD, MBA
Kevin Ong, PhD
Edmund Lau, MS
Daniel J. Berry, MD
Thomas P. Vail, MD
Steven M. Kurtz, PhD
Harry E. Rubash, MD
Publication date
01-02-2013
Publisher
Springer-Verlag
Published in
Clinical Orthopaedics and Related Research® / Issue 2/2013
Print ISSN: 0009-921X
Electronic ISSN: 1528-1132
DOI
https://doi.org/10.1007/s11999-012-2605-z

Other articles of this Issue 2/2013

Clinical Orthopaedics and Related Research® 2/2013 Go to the issue

Symposium: Papers Presented at the Annual Meetings of The Hip Society

What Factors Affect Posterior Dislocation Distance in THA?

Orthopaedic Healthcare Worldwide

Improving Value in Healthcare

Editorial

Editorial: Let’s Talk About Level IV: The Bones of a Good Retrospective Case Series

Symposium: Papers Presented at the Annual Meetings of The Hip Society

Alcohol Use in Elective Total Hip Arthroplasty: Risk or Benefit?

Emerging Ideas

Emerging Ideas: Novel 3-D Quantification and Classification of Cam Lesions in Patients With Femoroacetabular Impingement

Clinical Research

Can a Triple Pelvic Osteotomy for Adult Symptomatic Hip Dysplasia Provide Relief of Symptoms for 25 Years?